Vibert, Roseline http://orcid.org/0000-0001-5202-0212
Hasnaoui, Jasmine
Perrier, Alexandre
Lefebvre, Alexandra
Colas, Chrystelle
Dhooge, Marion
Basset, Noémie
Chansavang, Albain http://orcid.org/0000-0002-9835-2156
Desseignes, Camille
Duval, Alex http://orcid.org/0000-0003-1534-1724
Farelly, Solenne
Hamzaoui, Nadim
Laurent-Puig, Pierre http://orcid.org/0000-0001-8475-5459
Metras, Julie
Moliere, Diane
Muleris, Martine
Netter, Jeanne
Touat, Mehdi
Bielle, Franck http://orcid.org/0000-0001-6564-6388
Labreche, Karim
Nicolle, Romain http://orcid.org/0000-0001-8578-9095
Perkins, Géraldine
Warcoin, Mathilde
Coulet, Florence
Benusiglio, Patrick R. http://orcid.org/0000-0003-1003-1997
Article History
Received: 12 October 2022
Revised: 3 April 2023
Accepted: 13 April 2023
First Online: 24 April 2023
Competing interests
: PRB has received honoraria from AstraZeneca, MSD and BMS. The other authors declare no competing interests.
: The study was approved by the ethics evaluation committee of Inserm, the Institutional Review Board (IRB00003888, IORG0003254, FWA00005831) of the French Institute of medical research and Health (Opinion number 22-878).